Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Research Article

Impact of Educational Intervention on the Knowledge, Attitude, and Practice of Pharmacovigilance Among Nurses at a Tertiary Care Public Hospital

Author(s): Renuka Munshi* and Miteshkumar Maurya

Volume 18, Issue 1, 2023

Published on: 23 May, 2022

Page: [31 - 38] Pages: 8

DOI: 10.2174/1574886317666220426092537

Price: $65

Abstract

Background: Nursing students and employees remain the first point of contact in case a patient develops an adverse drug reaction in hospital settings. Thus, it is important for nurses to understand the importance of pharmacovigilance activity and implement the same in their practice. They can also contribute to drug safety by reducing medication errors and adverse drug reaction reporting.

Methods: After ethics approval, an observational questionnaire-based study was conducted in 2017 that involved nursing students and nursing employees (N=390) to assess their baseline knowledge, attitude, and practice toward pharmacovigilance. Participants who consented were enrolled and a pre-training survey was conducted. Pharmacovigilance sensitization/ training sessions were conducted in the same year after getting their baseline data. Three years later in 2021, the same questionnaire was distributed to a subset of nursing students and employees (N=299) to analyze any change in their knowledge, attitude, and practice towards the pharmacovigilance activity as a posttest. Pre and post sensitization session questionnaire-based survey data was analyzed to confirm the long-term impact of conducting such pharmacovigilance awareness training.

Results: The nurses’ overall performance before and after training in each of the domains of knowledge, attitude and practice were 17.53%, 72.86%, 39.69% in the pretest group, respectively, and post test scores were 30.77%, OR-3.04, p=0.0 (Knowledge), 85.92%, OR-0.14, p=0.0 (Attitude) and 37.21%, OR-0.08, p=0.08 (Practice) in the corresponding domain. Overall, there was a declining trend in the practice domain of the nurses response between the pre-test and post intervention groups however this decline was not statistically significant (p=0.08).

Conclusion: Pharmacovigilance awareness training and sensitization programs had an impact on the knowledge and attitude of nurses but there is a need to ensure that it is implemented in clinical practice.

Keywords: Sensitization, pharmacovigilance, nurses, adverse drug reaction, drug safety, PvPI.

[1]
Geneva, Switzerland: Office of Publications; 2002. World Health Organization (WHO) (a) world health organization. The importance on pharmacovigilance. safety Monitoring on Medicinal Products. 2002. Available from: https://apps.who.int/iris/handle/10665/67378 (last accessed on Apr 04, 2022).
[2]
Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J 2014; 22(2): 83-94.
[http://dx.doi.org/10.1016/j.jsps.2013.02.003] [PMID: 24648818]
[3]
Lavan AH, Gallagher P. Predicting risk of adverse drug reac-tions in older adults. Ther Adv Drug Saf 2016; 7(1): 11-22.
[http://dx.doi.org/10.1177/2042098615615472] [PMID: 26834959]
[4]
Giardina C, Cutroneo PM, Mocciaro E, et al. Adverse drug reactions in hospitalized patients: Results of the forward (fa-cilitation of reporting in hospital ward) study. Front Pharmacol 2018; 9: 350.
[http://dx.doi.org/10.3389/fphar.2018.00350] [PMID: 29695966]
[5]
Pirmohamed M, James S, Meakin S, et al. Adverse drug reac-tions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15-9.
[http://dx.doi.org/10.1136/bmj.329.7456.15] [PMID: 15231615]
[6]
Griffith R. Nurses must report adverse drug reactions. Br J Nurs 2013; 22(8): 484-5.
[7]
Schutte T, van Eekeren R, Richir M, et al. The adverse drug reaction reporting assignment for specialist oncology nurses: A preliminary evaluation of quality, relevance and education-al value in a prospective cohort study. Naunyn Schmiedebergs Arch Pharmacol 2018; 391(1): 17-26.
[http://dx.doi.org/10.1007/s00210-017-1430-z] [PMID: 29063137]
[8]
Angelis A, Pancani L, Steca P, et al. Testing an explanatory model of nurses’ intention to report adverse drug reactions in hospital settings. J Nurs Manag 2017; 25(4): 307-17.
[http://dx.doi.org/10.1111/jonm.12467] [PMID: 28127821]
[9]
Haider N, Mazhar F. Factors associated with underreporting of adverse drug reactions by nurses: A narrative literature re-view. Saudi J Health Sci 2017; 6(2): 71.
[http://dx.doi.org/10.4103/sjhs.sjhs_37_17]
[10]
Epitools - Epidemiological Calculators. 2021. Available from: https://epitools.ausvet.com.au/mcnemar (last accessed on 04/Mar/2022).
[11]
Veena RM, Kalpana L, Lavanya SH, Bharatkumar VD, Ma-nasa CR. Knowledge, attitude and practice of pharmacovigi-lance among nursing staff in BGS GIMS Hospital. Biomed Pharmacol J 2021; 14(1): 497-502.
[12]
Alan S, Ozturk M, Gokyildiz S, Avcibay B. Karataş Y. An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey. Indian J Pharmacol 2013; 45(6): 616-8.
[http://dx.doi.org/10.4103/0253-7613.121375] [PMID: 24347772]
[13]
Salehi T, Seyedfatemi N, Mirzaee MS, Maleki M, Mardani A. Nurses’ Knowledge, attitudes, and practice in relation to pharmacovigilance and adverse drug reaction reporting: A systematic review. BioMed Res Int 2021; 2021: 6630404.
[http://dx.doi.org/10.1155/2021/6630404] [PMID: 33937402]
[14]
Wadivkar P, Zad V, Vakharia M, Shah K. Assessment of knowledge of pharmacovigilance among the nurses of tertiary care hospital. Int J Basic Clin Pharmacol 2015; 1194-7.
[http://dx.doi.org/10.18203/2319-2003.ijbcp20151357]
[15]
Vural F, Ciftci S, Vural B. The knowledge, attitude and behav-iours of nurses about pharmacovigilance, adverse drug reac-tion and adverse event reporting in a state hospital. North Clin Istanb 2015; 1(3): 147-52.
[http://dx.doi.org/10.14744/nci.2014.41636] [PMID: 28058321]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy